SarcopeniaSARCSANCT03196622
Validation of a Screening Test for Sarcopenia in Older People
A study testing Handgrip test in people with Sarcopenia, run by University Hospital, Clermont-Ferrand at 1 site in France.
Trial summary
Identify the threshold which the handgrip strenght can be used as a screening test of sarcopenia. Handgrip strenght can be used in daily clinical practice to screen patients having sarcopenia to improve treatment and quality of life. Read more about this study
- Who is it for?
- Ages 75 years and older
- Conditions the study is for
- Sarcopenia
- What is being tested?
- Handgrip test
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 1,300 participants
- Where
- 1 siteFrance
- Study dates
- 11 Jul 2017to Jun 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 75 years and older
- All sexes
- No healthy volunteers
- Older adult
Who may be able to join
- ≥ 75 years old
Who cannot join
- Palliative care,
- Protection of vulnerable adults
Trial locations and contacts
1 site in 1 country.
France1 site, 1 recruiting
- Recruiting
CHU de Clermont-Ferrand
Clermont-Ferrand, Auvergne, 63003
Patrick LACARIN, 04 73 75 11 95, placarin@chu-clermontferrand.fr
Marie BLANQUET
About this study
Official title: Validation of a Screening Test of Sarcopenia in the Elderly People at Hospital and in Retirement Houses
Identify the threshold which the handgrip strenght can be used as a screening test of sarcopenia.
Handgrip strenght can be used in daily clinical practice to screen patients having sarcopenia to improve treatment and quality of life.
Read the detailed description
A cross-sectional multicentre study will be performed in hospital and retirement houses on patients ages 75 years old or more.
- Conditions
- Sarcopenia
- Being tested
- Handgrip test
- Keywords
- Sarcopenia, Elderly people, Hospitalization
- Medical subject headings
- Sarcopenia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Handgrip testDevice
Handgrip strenght can be used in daily clinical practice to screen patients having sarcopenia to improve treatment and quality of life.
| Study group | Role | What they receive |
|---|---|---|
| Older people | Experimental | A cross-sectional multicentre study will be performed in hospital and retirement houses on patients ages 75 years old or more. Receives: Device: Handgrip test |
What is being measured
The primary outcome is the main question the study is designed to answer.
Handgrip test could be used as a screening test of sarcopenia
Measured: at day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Jun 2017
- Study start11 Jul 2017
- Primary completionDec 2018 (estimated)
- Study completionJun 2019 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SarcopeniaStudies of the same condition, open and under way.
- More trials run by University Hospital, Clermont-FerrandThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 1,300 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Clermont-Ferrand
- Sponsor type
- University, hospital or other
- Collaborators
- Nutriset
- Responsible party
- Sponsor
- Investigators
- Marie BLANQUET, Principal investigator, University Hospital, Clermont-Ferrand
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03196622
- Sponsor's protocol ID
- CHU-339
- Other IDs
- 2016-A01254-47
- Acronym
- SARCSA
- Status last verified
- Jun 2017
- First submitted
- 21 Jun 2017
- Last updated
- 27 Jul 2017
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 27 Jul 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Validation of a Screening Test of Sarcopenia in the Elderly People at Hospital and in Retirement Houses
- ClinicalTrials.gov ID
- NCT03196622
- Acronym / sponsor ID
- SARCSA / CHU-339
- Conditions
- Sarcopenia
- Keywords
- Sarcopenia, Elderly people, Hospitalization
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 1,300 participants (estimated)
- Lead sponsor
- University Hospital, Clermont-FerrandUniversity, hospital or other
- Collaborators
- Nutriset
- Study start
- 11 Jul 2017 (actual)
- Primary completion
- Dec 2018 (estimated)
- Study completion
- Jun 2019 (estimated)
- First posted
- 23 Jun 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Identify the threshold which the handgrip strenght can be used as a screening test of sarcopenia.
Handgrip strenght can be used in daily clinical practice to screen patients having sarcopenia to improve treatment and quality of life.
Detailed description
A cross-sectional multicentre study will be performed in hospital and retirement houses on patients ages 75 years old or more.
Study design
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Older people | Experimental | Device: Handgrip testA cross-sectional multicentre study will be performed in hospital and retirement houses on patients ages 75 years old or more. |
Who may qualify
- Ages
- 75 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
Key inclusion criteria (1 listed)
- ≥ 75 years old
Key exclusion criteria (2 listed)
- Palliative care,
- Protection of vulnerable adults
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Handgrip testHandgrip strenght can be used in daily clinical practice to screen patients having sarcopenia to improve treatment and quality of life. | Device | Older people |
Primary outcome
Handgrip test could be used as a screening test of sarcopenia
Time frame: at day 1
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Jul 2017.
Related trials for Sarcopenia
Enrolling by invitation
Online Exercise Program for Transplant Patients: A Pilot Study
Kidney Transplantation, Physical Function
Not yet recruitingPhase 2
A Study of Bimagrumab in Participants With HFpEF
Heart Failure, Diastolic, Diastolic Heart Failure
Not yet recruiting
The Aim of the Study is to Decipher the Alterations in Signalling Pathways of Skeletal Muscle Stem Cells (Satellite Cells (SCs)) in Individuals With COPD, as Well as to Examine the Effect of Exercise Training on SCs.
COPD (Chronic Obstructive Pulmonary Disease), Sarcopenia in Elderly
Not yet recruitingPhase 2
MF-300 for Treatment of Age-Related Sarcopenia
Sarcopenia in Elderly
Not yet recruitingObservational study
Validation of Uzbek SARC-F and IPAQ-SF Questionnaires in Adults With and Without Hypothyroidism
Hypothyroidism, Psychometrics
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Marie BLANQUET principal investigator
University Hospital, Clermont-Ferrand
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Handgrip test in people with Sarcopenia, run by University Hospital, Clermont-Ferrand at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 27 Jul 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Patrick LACARIN (04 73 75 11 95, placarin@chu-clermontferrand.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Handgrip test could be used as a screening test of sarcopenia (time frame: at day 1). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jul 2017.